Jung+ focuses on biotech solutions for slowing aging and extending healthy lifespan through its Total Longevity SystemN.
Jung+ Longevity has raised $573K in total funding. The most recent round was Pre-Seed. The last funding was announced in January 2023.
Jung+ Longevity's investors include Fady Hannah-Shmouni, MD FRCPC, Sebastian Brunemeier, Khalili Brothers, Abdullah Zaid, Ghalib Alireza.
Jung+ Longevity is headquartered in New York, United States.
Jung+ focuses on biotech solutions for slowing aging and extending healthy lifespan through its Total Longevity SystemN.
Jung+ Longevity is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Jung+ Longevity — Funding & Investors." VCBacked, January 1, 2023, https://www.vcbacked.co/company/jung-longevity. Accessed August 1, 2026.
VCBacked. (2023). Jung+ Longevity — Funding & Investors. Retrieved August 1, 2026, from https://www.vcbacked.co/company/jung-longevity
{{cite web |title=Jung+ Longevity — Funding & Investors |url=https://www.vcbacked.co/company/jung-longevity |website=VCBacked |access-date=August 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated